Covered recipient · General Payments record
ANDREW ZHUANG WANG
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2018–2024
$60,224.27
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,849.00 | 3 |
| Food and Beverage | $940.79 | 7 |
| Travel and Lodging | $897.86 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $5,139.76 | 2 |
| AstraZeneca UK Limited | $3,500.00 | 1 |
| Acerta Pharma LLC | $1,487.45 | 2 |
| Archimmune Therapeutics Inc. | $897.86 | 1 |
| Exelixis Inc. | $342.82 | 2 |
| PFIZER INC. | $278.09 | 2 |
| Janssen Scientific Affairs, LLC | $41.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Archimmune Therapeutics Inc. | $897.86 | 02/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152820748 | CMS |
| AstraZeneca Pharmaceuticals LP | $137.45 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105678773 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,350.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105493269 | CMS |
| AstraZeneca UK Limited | $3,500.00 | 10/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093901967 | CMS |
| BeiGene USA, Inc. | $140.76 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120852925 | CMS |
| BeiGene USA, Inc. | $4,999.00 | 09/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120852923 | CMS |
| Exelixis Inc. | $174.00 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138555218 | CMS |
| Exelixis Inc. | $168.82 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138555220 | CMS |
| Janssen Scientific Affairs, LLC | $41.67 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078853848 | CMS |
| PFIZER INC. | $135.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476214 | CMS |
| PFIZER INC. | $143.09 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131903685 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.